พบ "Public health policy"ทั้งหมด 1,293 ผลลัพธ์
เรียงลำดับตาม
เรียงลำดับตาม
ความเกี่ยวข้อง
ต่อยอดความรู้ HTA: พัฒนาศักยภาพทีมวิจัยเพื่อระบบสุขภาพไทยยั่งยืน
การพัฒนานโยบายสุขภาพที่ยั่งยืนต้องอาศัยหลักฐานเชิงประจักษ์ (evidence-based decision making) เพื่อให้การตัดสินใจโปร่งใสเป็นระบบ และใช้ทรัพยากรอย่างคุ้มค่า ทีมวิจัยจึงมีบทบาทสำคัญในการรวบรวมและสังเคราะห์ข้อมูลเพื่อสนับสนุนกระบวนการนโยบาย ทั้งนี้ องค์การอนามัยโลก (World Health Organization: WHO) ได
When access outpaces ethics: reflections on dialysis expansion and health system integrity
Thailand’s dialysis policy reform, introduced in 2022, aimed to enable universal access to life-sustaining dialysis, but instead exposed systemic vulnerabilities that undermined dialysis quality, compromised patient safety and threatened sustainability of care. These outcomes highlight three ethical
iDSI Vietnam
This project is part of the international Decision Support Initiative (iDSI), an innovative global partnership between leading government institutions, universities, and think tanks in the field of healthcare priority-setting. iDSI uniquely provides intellectual insight with hands-on field expertise, and delivers peer-to-peer support to policymaker
Prince Mahihol Award Conference (PMAC)
The Prince Mahidol Award Conference (PMAC) is an annual international conference focusing on policy-related health issues. PMAC is co-hosted by the Prince Mahidol Award Foundation with support from other key related partners. In 2021, HITAP has led one webinar session and co-led two others with international partners. For more information, please v
Towards the introduction of pneumococcal conjugate vaccines in Bhutan: A cost-utility analysis to determine the optimal policy option
Abstract
Background
Due to competing health priorities and limited resources, many low-income countries, even those with a high disease burden, are not able to introduce pneumococcal conjugate vaccines.
Objective
To determine the cost-utility of 10- and 13-valent pneumococcal conjugate vacci
Tackling the 3 Big Challenges Confronting Health Technology Assessment Development in Asia: A Commentary
ABSTRACT
There has been continuous development in the field of health technology assessment (HTA) owing to the added value of HTA in supporting healthcare reimbursement decisions. Collaboration and engagement among countries in Asia has been carried out to share experiences and learning on the ba
Institutionalizing Evidence-Informed Priority Setting for Universal Health Coverage: Lessons From Indonesia
Abstract
Planning and administering Universal Health Coverage (UHC) policies involve complex and critical decisions, especially in resource-scarce and densely populated settings such as Indonesia. Increasing investments alone do not ensure success and sustainability of UHC, and defining prioritie
The Trouble With ‘Doctor Knows Best’
Doctors were told last month that we should stop doing so many screenings for prostate cancer with the prostate-specific antigen test. We learned that sigmoidoscopy is a cheaper, easier and effective alternative to colonoscopy for colon cancer screening. And a study I led turned up strong evidence t
Breast cancer screening does ‘more good than harm’
Breast cancer screening saves the lives of two women for every one patient who receives unnecessary treatment, according to a major European review.There has been a fierce debate about the use of screening, and policy is being reviewed in England.The latest study, published in the Journal of Medical
Introduction of early health technology assessment for innovators, clinicians, and funders
Abstract
Health technology faces rising costs, system complexities, and gaps between development and coverage policies, limiting translation into practice. Traditional health technology assessment (HTA) evaluates technologies at late stages, providing little support if a technology fails to secur
10 / หน้า